As we reviewed the molecular characteristics of the four biomarkers among UTUC tumor origin and IVR specimens, we observed that the co-occurrence of FGFR3 and p53 expression increased during the process of bladder cancer progression. This evidence concerns the gene FGFR3 and renal pelvis/ureter urothelial carcinoma.